Literature DB >> 30252728

Histologic Features of Hysterectomy Specimens From Female-Male Transgender Individuals.

Mahmoud A Khalifa1, Aimi Toyama, Molly E Klein, Victor Santiago.   

Abstract

Histologic changes in the female genital tract after prolonged androgen stimulation have been described in the past. However, these changes have not been systematically addressed in hysterectomy specimens from subjects undergoing surgical gender-reassignment, typically after treatment with exogenous androgens. The current study aims to provide practicing pathologists with a list of expected histologic features in hysterectomy specimens from female-male transgender individuals. Twenty-seven hysterectomy with bilateral salpingo-oophorectomy specimens were identified from our Laboratory Information System. Slides were retrieved and reviewed for features associated with androgen exposure. Clinical information for the 27 subjects (20-46 yr old, mean=29 yr) was obtained from the electronic medical records. Twenty-four subjects had received androgen 19 mo to 24 yr preoperatively. Focal decidua-like endometrial stromal change with glandular paucity was present in 16/27 (59%) uteri associated with predominantly inactive endometrial glands. Ectocervical or transformation zone transitional cell metaplasia was present in 17/27 (63%) subjects. Bilateral cystic follicles were present in all 23 subjects who underwent bilateral salpingo-oophorectomy and had preoperative androgen exposure. In these ovaries, follicular density appeared higher than that expected for age with counts ranging from 1.5 to 32.5 follicles/mm (average=10.7 follicles/mm). Predominantly inactive, sparse endometrial glands with focal decidua-like stromal change, cervical transitional cell metaplasia, bilateral cystic follicles and higher follicular density are observed in the majority of specimens from female-male transgender individuals. These histologic changes correlate with prolonged preoperative androgen administration. The significance of these findings relies on recognizing the spectrum of androgen-related histologic alterations and not confusing transitional cell metaplasia with cervical dysplasia.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30252728     DOI: 10.1097/PGP.0000000000000548

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  4 in total

1.  Cervicovaginal cytology, HPV testing and vaginal flora in transmasculine persons receiving testosterone.

Authors:  Lawrence Hsu Lin; Fang Zhou; Esther Elishaev; Samer Khader; Andrea Hernandez; Alan Marcus; Esther Adler
Journal:  Diagn Cytopathol       Date:  2022-08-08       Impact factor: 1.390

2.  Endometriosis in transmasculine individuals.

Authors:  Cecile A Ferrando
Journal:  Reprod Fertil       Date:  2022-04-20

3.  Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.

Authors:  Frances W Grimstad; Kylie G Fowler; Erika P New; Cecile A Ferrando; Robert R Pollard; Graham Chapman; Meredith Gray; Veronica Gomez Lobo
Journal:  J Sex Med       Date:  2020-07-20       Impact factor: 3.802

Review 4.  Fertility Options for the Transgender and Gender Nonbinary Patient.

Authors:  Allison C Mayhew; Veronica Gomez-Lobo
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.